Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dreyfus S&P 500 Index Fund (PEOPX)

48.77
Net Asset Value
-1.51%
1 Day
-5.67%
Year-to-Date
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
0.51%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks to match the performance of the Standard & Poor's  500 Composite Stock Price Index. To pursue its goal, the fund generally is fully invested in stocks included in the S&P 500  Index and in futures whose performance is tied to the index. It generally invests in all 500 stocks in the S&P 500  Index in proportion to their weighting in the index. The S&P 500  Index is an unmanaged index of 500 common stocks chosen to reflect the industries of the U.S. economy and is often considered a proxy for the stock market in general. The fund is non-diversified.

Performance

1 month-8.00% 3 years+12.83%
3 months-7.93% 5 years+13.56%
1 year-2.28% Since inception+8.95%
Data through --

Peer Comparisonvs. Large blend

 PEOPXCategory
Performance 5-yr return+13.56%+15.84%
Expense ratio0.51%1.09%
Risk 5 year sharpe ratio1.301.13
Net assets$2.9B$3.6B
Average market cap$72.5B$94.6B
Average P/E19.018.7
Portfolio turnover4%4%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyDreyfus
Fund manager & tenureThomas Durante / 15 Years
Minimal initial investment$2,500.00
Minimum IRA investment$750.00

Holdings

U.S. stock97.12%
Cash1.55%
International stock1.29%
Fixed income0.04%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 16.34%
Energy 12.11%
Industrial materials 11.82%
Consumer goods 11.08%
Healthcare 10.71%
Top 10 Holdings
Portfolio weighting
AAPL Apple3.90%
MSFT Microsoft1.93%
XOM Exxon Mobil1.88%
JNJ Johnson & Johnson1.46%
GE General Electric1.45%
WFC Wells Fargo1.42%
JPM JPMorgan Chase1.36%
BRKB Berkshire Hathaway1.34%
PG Procter & Gamble1.15%
PFE Pfizer1.11%

Partner Offers